Pear Therapeutics- Warrants (01/12/2026) Accounts Payable

Pear Therapeutics- Warrants (01/12/2026) (PEARW) currently reports a accounts payable of $3.3M as of December 2022. That compares with $1.8M in the prior-year period — up 80.7% year over year. Use the charts on this page to explore Pear Therapeutics- Warrants (01/12/2026)'s accounts payable history and peer comparisons.

Pear Therapeutics- Warrants (01/12/2026)'s accounts payable increased from $1.8M to $3.3M — a 80.7% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pear Therapeutics- Warrants (01/12/2026) reported $3.3M in accounts payable as of December 2022. That compares with $1.8M in the prior-year period — up 80.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $3.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pear Therapeutics- Warrants (01/12/2026), and consider following PEARW for alerts when major investors trade the stock.